Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress
Go back to Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress| (NASDAQ: LTRN) | Delayed: 1.78 -0.06 (3.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.84 | 52 Week High | $ | |||
| Open | $1.82 | 52 Week Low | $ | |||
| Day High | $1.86 | P/E | N/A | |||
| Day Low | $1.76 | EPS | $ | |||
| Volume | 168,769 | |||||

